Irvine-based Epiomed Therapeutics, a developer of small-molecule, anti-emetic and anti-motion sickness compounds, said this week that it raised a Series A funding round. The firm said the round came from NDI Capital. Financial details of the funding were not disclosed. The firm said the funds will go to develop its lead anti-emetic compound, used to prevent nausea and vomiting. READ MORE>>
BlackBerry 8703e PDA Smartphone in Mint Condition for Verizon Wireless with No ContractRefurbished BlackBerry 8703e PDA Bluetooth Ev-DO Phone for Verizon. The BlackBerry 8703e smartphone makes it easy to stay connec…
LG KP500 Cookie Unlocked Phone with 3.2 MP Camera and Digital Media Player–International Version with Warranty (Black)LG KP500 Cookie phone features a 3-inch wide full touch screen that has more screen “real estate” to better enjoy watching vid…
